These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25240454)

  • 1. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.
    Zellweger MJ; Maraun M; Osterhues HH; Keller U; Müller-Brand J; Jeger R; Pfister O; Burkard T; Eckstein F; von Felten S; Osswald S; Pfisterer M
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):1001-10. PubMed ID: 25240454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients.
    Haaf P; Ritter M; Grize L; Pfisterer ME; Zellweger MJ;
    J Nucl Cardiol; 2017 Jun; 24(3):772-782. PubMed ID: 28091969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Shaw LJ; Cerqueira MD; Brooks MM; Althouse AD; Sansing VV; Beller GA; Pop-Busui R; Taillefer R; Chaitman BR; Gibbons RJ; Heo J; Iskandrian AE
    J Nucl Cardiol; 2012 Aug; 19(4):658-69. PubMed ID: 22527794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
    Young LH; Wackers FJ; Chyun DA; Davey JA; Barrett EJ; Taillefer R; Heller GV; Iskandrian AE; Wittlin SD; Filipchuk N; Ratner RE; Inzucchi SE;
    JAMA; 2009 Apr; 301(15):1547-55. PubMed ID: 19366774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
    Lièvre MM; Moulin P; Thivolet C; Rodier M; Rigalleau V; Penfornis A; Pradignac A; Ovize M;
    Trials; 2011 Jan; 12():23. PubMed ID: 21269454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Prognostic Importance of Abnormal Positron Emission Tomography Among Asymptomatic Patients With Diabetes Mellitus.
    Patel KK; Singh A; Peri-Okonny PA; Patel FS; Kennedy KF; Sperry BW; Thompson RC; McGhie AI; Spertus JA; Shaw LJ; Bateman TM
    JACC Cardiovasc Imaging; 2024 Mar; 17(3):301-310. PubMed ID: 37855795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate].
    Soboleva GN; Minasyan AA; Gaman SA; Rogoza AN; Molina LP; Soboleva TV; Shariya MA; Ternovoy SK; Karpov YA
    Ter Arkh; 2023 May; 95(4):309-315. PubMed ID: 38158978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary risk equivalence of diabetes assessed by SPECT-MPI.
    Morales DCV; Bhavnani SP; Ahlberg AW; Pullatt RC; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2019 Aug; 26(4):1093-1102. PubMed ID: 29214611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretest models for predicting abnormal stress single-photon emission computed tomography myocardial perfusion imaging.
    Megna R; Assante R; Zampella E; Gaudieri V; Nappi C; Cuocolo R; Mannarino T; Genova A; Green R; Cantoni V; Acampa W; Petretta M; Cuocolo A
    J Nucl Cardiol; 2021 Oct; 28(5):1891-1902. PubMed ID: 31823327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry.
    Han D; Rozanski A; Gransar H; Tzolos E; Miller RJH; Sharir T; Einstein AJ; Fish MB; Ruddy TD; Kaufmann PA; Sinusas AJ; Miller EJ; Bateman TM; Dorbala S; Di Carli M; Liang JX; Hu LH; Dey D; Berman DS; Slomka PJ
    J Nucl Cardiol; 2022 Dec; 29(6):3003-3014. PubMed ID: 34757571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends of abnormal myocardial perfusion imaging in a cohort of Italian subjects: Relation with cardiovascular risk factors.
    Megna R; Zampella E; Assante R; Nappi C; Gaudieri V; Mannarino T; Cantoni V; Green R; Daniele S; Mainolfi CG; Acampa W; Petretta M; Cuocolo A
    J Nucl Cardiol; 2020 Dec; 27(6):2167-2177. PubMed ID: 30734219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between myocardial perfusion imaging, coronary calcium score, and endothelial function in asymptomatic diabetics and controls.
    Peix A; Cabrera LO; Heres F; Rodríguez L; Valdés A; Valiente J; García R; Licea M; Mendoza V; Gárciga F; Rodríguez Y; Carrillo R; Mena E; Fernández Y; Montero M; Dondi M
    J Nucl Cardiol; 2011 May; 18(3):398-406. PubMed ID: 21432001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WOMEN study: what is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study design.
    Mieres JH; Shaw LJ; Hendel RC; Heller GV
    J Nucl Cardiol; 2009; 16(1):105-12. PubMed ID: 19152135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Coronary Artery Disease in Patients with Diabetes.
    Saraste A; Knuuti J; Bax J
    Curr Cardiol Rep; 2023 Dec; 25(12):1865-1871. PubMed ID: 37982936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a meta-analysis.
    Acampa W; Cantoni V; Green R; Maio F; Daniele S; Nappi C; Gaudieri V; Punzo G; Petretta M; Cuocolo A
    J Nucl Cardiol; 2014 Oct; 21(5):893-902; quiz 890-2, 903-5. PubMed ID: 24925624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of undiagnosed coronary artery disease associated with infrapopliteal artery occlusion from a multicenter study.
    Imaeda S; Kuno T; Hirano K; Kodaira M; Anzai H; Numasawa Y
    Heart Vessels; 2020 Mar; 35(3):307-311. PubMed ID: 31473802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD.
    Stirrup JE; Underwood SR
    J Nucl Cardiol; 2017 Dec; 24(6):1960-1964. PubMed ID: 28836225
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening asymptomatic patients with type 2 diabetes is recommended-Con.
    Gibbons RJ
    J Nucl Cardiol; 2015 Dec; 22(6):1229-32. PubMed ID: 26391500
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening asymptomatic patients with type 2 diabetes is recommended: Pro.
    Petretta M; Cuocolo A
    J Nucl Cardiol; 2015 Dec; 22(6):1225-8. PubMed ID: 26391499
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of ischemia on myocardial perfusion scintigraphy of pre-and postmenopausal women.
    Santos DA; Navarro WY; Alexandre LM; Cestari PF; Smanio PE
    Arq Bras Cardiol; 2013 Dec; 101(6):487-94. PubMed ID: 24217403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.